Phase Transition and Orientational Disorder of the Cation in [(PyO)(H/D)][AuCl4] (PyO = C5H5NO) Crystal.

Autor: Asaji, T.¹ asaji@chs.nihon-u.ac.jp, Akiyama, E.¹, Tajima, F.², Eda, K.², Hashimoto, M.², Furukawa, Y.³

Publikováno v: Hyperfine Interactions. 2004, Vol. 159 Issue 1-4, p103-108. 6p. 1 Diagram, 2 Graphs.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phase Transition and Orientational Disorder of the Cation in [(PyO)(H/D)][AuCl4] (PyO = C5H5NO) Crystal.

Autor: Maier, K., Vianden, R., Asaji, T., Akiyama, E., Tajima, F., Eda, K., Hashimoto, M., Furukawa, Y.

Publikováno v: HFI/NQI 2004; 2005, p545-550, 6p

Successive phase transitions of [(PyO)(H/D)][AuCl_4_] (PyO=C_5_H_5_NO)

Autor: OGUNI, MASAHARU

Publikováno v: Solid State Commun.. 137:488-491

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=jairo_______::01bf6202bea62673d1c4ec41ffc965ed
http://t2r2.star.titech.ac.jp/cgi-bin/publicationinfo.cgi?q_publication_content_number=CTT100527298

Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.

Autor: Shin J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Park S; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim KH; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Korea.; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea., Shin EC; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea., Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Sun JM; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Noh JM; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Pyo H; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publikováno v: Cancer research and treatment [Cancer Res Treat] 2024 Oct; Vol. 56 (4), pp. 1084-1095. Date of Electronic Publication: 2024 Apr 30.